Glyxambi (empagliflozin and linagliptin) is used to lower blood sugar and treat type 2 diabetes. Glyxambi is the only drug in the SGLT2 inhibitor/gliptin combinations class. There are currently no generic alternatives to Glyxambi.

Check our savings tips for patient assistance programs and other ways to reduce your cost. Glyxambi is not covered by most Medicare and insurance plans.

With the Patient Assistance Program from Boehringer Ingelheim, you can receive your medication free of charge.